St. Jude Heritage Medical Group

Fullerton, California 92835

1 studies enrolling now · 10 studies all time

What they study most

Breast Neoplasms, Cancer, Colorectal Cancer, Early Breast Cancer, End of Life, HER2+ Metastatic Breast Cancer (MBC), Heart Failure, Congestive, Mantle Cell Lymphoma, Metastatic gpNMB Over-expressing Triple Negative Breast Cancer, Myocardial Infarction, Neoplasms, Colorectal, Non-Hodgkin's Lymphoma

Studies at this site

• Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer — Recruiting now
• A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer — Running, not enrolling
• A Study of Nipocalimab in Adults With Primary Sjogren's Syndrome (pSS) — Completed
• A Study of Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer Who Have Received Two or More Prior HER2 Directed Regimens in the Metastatic Setting — Completed
• A Study Assessing the Safety and Efficacy of Adding Ipatasertib to Paclitaxel Treatment in Participants With Breast Cancer That Has Spread Beyond the Initial Site, and the Cancer Does Not Have Certain Hormonal Receptors — Completed
• Study of CS-7017 in Combination With FOLFIRI in Subjects With Metastatic Colorectal Cancer Who Failed First-Line Therapy — Completed
• Study of Glembatumumab Vedotin (CDX-011) in Patients With Metastatic, gpNMB Over-Expressing, Triple Negative Breast Cancer — Completed
• IMPROVE HF: Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting — Completed
• Study to Assess the Effect of Treatment With Bendamustine in Combination With Rituximab on QT Interval in Patients With Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL) — Completed
• Study of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma — Completed